Table 2. Correlation between RKIP expression and clinicopathological characteristics in nasopharyngeal carcinoma (n = 149, χ2 test).
Variables | N | RKIP | ||
---|---|---|---|---|
low | high | P | ||
Gender | ||||
Male | 110 | 67 | 43 | |
Female | 39 | 25 | 14 | 0.724 |
Age (y) | ||||
< 47 | 68 | 42 | 26 | |
≥ 47 | 81 | 50 | 31 | 0.996 |
Primary tumor (T) stage | ||||
T1–2 | 74 | 43 | 31 | |
T3–4 | 75 | 49 | 26 | 0.364 |
Lymph node (N) metastasis | ||||
N0 | 63 | 33 | 30 | |
N1–3 | 86 | 59 | 27 | 0.044 |
Clinical TNM stage | ||||
I–II | 41 | 17 | 24 | |
III–IV | 108 | 75 | 33 | 0.002 |
Radiation response | ||||
Sensitivity | 74 | 28 | 46 | |
Resistance | 75 | 64 | 11 | 0.000 |